FBLG Insider Trading

Insider Ownership Percentage: 20.80%
Insider Buying (Last 12 Months): $35,235.00
Insider Selling (Last 12 Months): $0.00

FibroBiologics Insider Trading History Chart

This chart shows the insider buying and selling history at FibroBiologics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

FibroBiologics Share Price & Price History

Current Price: $1.17
Price Change: Price Decrease of -0.12 (-9.30%)
As of 02/14/2025 02:12 PM ET

This chart shows the closing price history over time for FBLG up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

FibroBiologics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/12/2024Hamid KhojaInsiderBuy10,000$1.90$19,000.0011,250View SEC Filing Icon  
8/12/2024Pete O'heeronCEOBuy8,500$1.91$16,235.006,056,647View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for FibroBiologics (NASDAQ:FBLG)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at FBLG by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

FibroBiologics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2025Raymond James Financial Inc.18,642$37K0.0%N/A0.051%Search for SEC Filing on Google Icon
2/13/2025Cerity Partners LLC78,101$0.16M0.0%+49.9%0.215%Search for SEC Filing on Google Icon
2/12/2025O Shaughnessy Asset Management LLC40,404$81K0.0%N/A0.111%Search for SEC Filing on Google Icon
2/11/2025Virtu Financial LLC14,862$30K0.0%N/A0.041%Search for SEC Filing on Google Icon
2/11/2025Intech Investment Management LLC12,653$25K0.0%N/A0.035%Search for SEC Filing on Google Icon
2/7/2025Cascade Financial Partners LLC282,601$0.57M0.1%-6.6%0.803%Search for SEC Filing on Google Icon
2/6/2025Raymond James Financial Inc.18,642$37K0.0%N/A0.053%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC39,958$0.12M0.0%+363.2%0.115%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC599,760$1.85M0.0%+90.0%1.706%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC39,958$0.12M0.0%+363.2%0.114%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC11,852$37K0.0%N/A0.034%Search for SEC Filing on Google Icon
11/15/2024State Street Corp475,837$1.47M0.0%+26.5%1.353%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company10,264$32K0.0%N/A0.029%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.69,732$0.22M0.0%+5.2%0.198%Search for SEC Filing on Google Icon
10/22/2024Symphony Financial Ltd. Co.23,772$76K0.0%N/A0.067%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP16,702$83K0.0%-67.9%0.047%Search for SEC Filing on Google Icon
8/12/2024Mercer Global Advisors Inc. ADV10,272$51K0.0%N/A0.029%Search for SEC Filing on Google Icon
8/6/2024Fund Evaluation Group LLC1,055,105$5.27M0.3%N/A3.001%Search for SEC Filing on Google Icon
8/6/2024Cahaba Wealth Management Inc.14,702$73K0.0%N/A0.041%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers23,057$0.12M0.0%N/A0.065%Search for SEC Filing on Google Icon
7/31/2024Cascade Financial Partners LLC315,055$1.57M0.2%N/A0.882%Search for SEC Filing on Google Icon
7/31/2024Concurrent Investment Advisors LLC35,283$0.18M0.0%N/A0.099%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp68,558$0.34M0.0%N/A0.192%Search for SEC Filing on Google Icon
7/23/2024RMR Wealth Builders37,360$0.19M0.0%N/A0.105%Search for SEC Filing on Google Icon
7/18/2024Saxon Interests Inc.21,214$0.11M0.1%N/A0.059%Search for SEC Filing on Google Icon
7/17/2024ERn Financial LLC31,819$0.16M0.0%N/A0.089%Search for SEC Filing on Google Icon
7/15/2024Transform Wealth LLC133,890$0.67M0.1%N/A0.375%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
FibroBiologics logo
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. It holds 150+ U.S. and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics, Inc. was incorporated in 2021 and is based in Houston, Texas.
Read More on FibroBiologics

Today's Range

Now: $1.17
Low: $1.06
High: $1.28

50 Day Range

MA: $1.95
Low: $1.29
High: $2.49

52 Week Range

Now: $1.17
Low: $1.06
High: $15.50

Volume

652,714 shs

Average Volume

394,012 shs

Market Capitalization

$42.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of FibroBiologics?

FibroBiologics' top insider shareholders include:
  1. Pete O'heeron (CEO)
  2. Hamid Khoja (Insider)
Learn More about top insider investors at FibroBiologics.

Who are the major institutional investors of FibroBiologics?

FibroBiologics' top institutional investors include:
  1. Cascade Financial Partners LLC — 0.80%
  2. Cerity Partners LLC — 0.21%
  3. O Shaughnessy Asset Management LLC — 0.11%
  4. Raymond James Financial Inc. — 0.05%
  5. Raymond James Financial Inc. — 0.05%
  6. Virtu Financial LLC — 0.04%
Learn More about top institutional investors of FibroBiologics stock.

Which major investors are selling FibroBiologics stock?

Within the last quarter, FBLG stock was sold by these institutional investors:
  1. Cascade Financial Partners LLC

Which major investors are buying FibroBiologics stock?

Within the last quarter, FBLG stock was acquired by institutional investors including:
  1. O Shaughnessy Asset Management LLC
  2. Cerity Partners LLC
  3. Raymond James Financial Inc.
  4. Raymond James Financial Inc.
  5. Virtu Financial LLC
  6. Intech Investment Management LLC
During the previous year, these company insiders have bought FibroBiologics stock:
  1. Pete O'heeron (CEO)
  2. Hamid Khoja (Insider)
Learn More investors buying FibroBiologics stock.